Clin Mol Hepatol > Volume 23(3); 2017 > Article |
|
n | Prevalence (standardized error) | n | Prevalence (standardized error) | n | Prevalence (standardized error) | ||||
---|---|---|---|---|---|---|---|---|---|
≥19 years old | 15,795 | 0.7 | (0.1) | 6,806 | 0.6 | (0.1) | 8,989 | 0.8 | (0.1) |
≥30 years old | 13,915 | 0.8 | (0.1) | 6,011 | 0.7 | (0.1) | 7,904 | 0.9 | (0.1) |
Age (years) | |||||||||
10-18 | 1,969 | 0.1 | (0.1) | 1,045 | 0.1 | (0.1) | 924 | 0.1 | (0.1) |
19-29 | 1,880 | 0.2 | (0.1) | 795 | 0.1 | (0.1) | 1,085 | 0.3 | (0.2) |
30-39 | 2,818 | 0.3 | (0.1) | 1,208 | 0.2 | (0.1) | 1,610 | 0.3 | (0.2) |
40-49 | 2,955 | 0.5 | (0.2) | 1,287 | 0.6 | (0.3) | 1,668 | 0.5 | (0.2) |
50-59 | 3,125 | 0.9 | (0.2) | 1,302 | 0.8 | (0.2) | 1,823 | 1.0 | (0.3) |
60-69 | 2,729 | 1.3 | (0.2) | 1,234 | 1.2 | (0.3) | 1,495 | 1.3 | (0.3) |
70+ | 2,288 | 1.9 | (0.4) | 980 | 1.4 | (0.4) | 1,308 | 2.2 | (0.5) |
Residence (standardized) | |||||||||
Dong | 14,347 | 0.5 | (0.1) | 6,273 | 0.4 | (0.1) | 8,074 | 0.5 | (0.1) |
Eub/Myun | 3,417 | 0.9 | (0.3)* | 1,578 | 0.9 | (0.3)* | 1,839 | 0.9 | (0.4)* |
Income (standardized) | |||||||||
Low | 4,277 | 0.6 | (0.1) | 1,895 | 0.5 | (0.1)* | 2,382 | 0.8 | (0.2)* |
Mid-low | 4,455 | 0.6 | (0.1) | 1,984 | 0.5 | (0.1)* | 2,471 | 0.6 | (0.1) |
Mid-high | 4,442 | 0.6 | (0.1) | 1,954 | 0.5 | (0.2)* | 2,488 | 0.7 | (0.2)* |
High | 4,437 | 0.4 | (0.1) | 1,952 | 0.4 | (0.1)* | 2,485 | 0.5 | (0.1)* |
Years |
Cases of hepatitis C |
||
---|---|---|---|
Total | Male | Female | |
2013 | 3,703 | 1,832 | 1,871 |
2014 | 4,126 | 2,043 | 2,083 |
2015 | 4,609 | 2,217 | 2,392 |
2016 (up to August) | 4,003 | 1,911 | 2,092 |
Do Young Kim
https://orcid.org/0000-0002-8327-3439
Current status and outcome of liver transplantation in South Korea2022 January;28(1)
History and future of hepatitis B virus control in South Korea2021 October;27(4)
Current and future strategies for the treatment of chronic hepatitis C2021 April;27(2)